Biostatistics Expertise
-
Adaptive Trial Design - Design and implementation of the next generation of biostatistics
-
Recurrent Events Analysis - Making effective use of critical study endpoints
-
Meta-Analysis - Efficient combinations of critical data from muliple datasets
-
Modeling and Simulation - Evaluating the robustness and validity of trial designs
-
Independent statistician on Data and Safety Monitoring Boards and support at regulatory meetings worldwide
Therapeutic Experience
Type-2 diabetes, schizophrenia, depression, stroke and Alzheimer's disease - Breast Cancer, Cervical Cancer, Leukemia, Hodgkin's Disease, Prostate, Sarcoma, Non-small Cell Lung Cancer - Infectious Diseases (Anti-Bacterial and HIV/AIDS, CMV, HSV, HCV) - Local Anesthetics and Analgesics - Cardiology - Urology - Rheumatoid Arthritis - Neurology - Psoriasis
Elite Status Expert with IMS ExpertServices
Our Recent Research Projects
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
LEADER Trial Investigators
Efficacy of Plinabulin vs Pegfilgrastim for Prevention
of Chemotherapy-Induced Neutropenia in Adults
With Non–Small Cell Lung Cancer- A Phase 2 Randomized Clinical Trial
JAMA Oncology